GLP-1 medications may be appropriate for adults with: BMI 30 kg/m BMI 27 kg/m with obesity-related conditions such as diabetes, hypertension, sleep apnea, or fatty liver disease Difficulty losing weight despite lifestyle changes Treatment suitability should always be determined by an endocrinologist after a comprehensive evaluation
Add moderate cardiovascular exercise (walking, cycling, swimming) for heart health and calorie expenditure, but do not rely on cardio alone
This is not about passing a test
Cummings discussed the evidence for the medications, which, despite their relative infancy, he has prescribed to more than 1,000 patients
Regular monitoring allows her to review progress, treatment tolerance, potential side effects, and any adjustments needed to support safer, sustainable weight management
Active GLP-1 levels were determined by using an active GLP-1 ELISA kit (EGLP-35K, Merck/millipore) according to the manufacturers instructions